Jie He

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 64

Top Topics

Squamous Cell Carcinoma

Long Noncoding Rna

Small Cell Lung Cancer

Top Venues

Signal transduction and targeted therapy

Thoracic cancer

Cancer medicine

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chaoqi Zhang, Guochao Zhang, Liyan Xue, Zhihui Zhang, Qingpeng Zeng, Peng Wu, Lide Wang, Zhaoyang Yang, Bo Zheng, Fengwei Tan, Qi Xue, Shugeng Gao, Nan Sun, Jie He
Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8+ T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China. International journal of surgery (London, England) (2023)
Xinfeng Wang, Yuan Li, Runsen Jin, Sufei Zheng, Yuejun Luo, Peng Wu, Zhanyu Wang, Yuxin Yao, Nan Sun, Jie He
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy (2023)
Dongyu Li, Jingnan Wang, Chengming Liu, Yuejun Luo, Haiyan Xu, Yan Wang, Nan Sun, Jie He
Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs. Biomedicines 11 (4) (2023)
Xinfeng Wang, Yuan Li, Runsen Jin, Sufei Zheng, Yuejun Luo, Peng Wu, Zhanyu Wang, Yuxin Yao, Nan Sun, Jie He
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
Xinfeng Wang, Yuan Li, Runsen Jin, Sufei Zheng, Yuejun Luo, Peng Wu, Zhanyu Wang, Yuxin Yao, Nan Sun, Jie He
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
Enzhi Yin, Nan Sun, Jie He
Tumor-draining lymph node-derived tumor-specific memory CD8 + T cells: a key player in PD-1/PD-L1 immunotherapy. Signal transduction and targeted therapy 8 (1) (2023)
Enzhi Yin, Nan Sun, Jie He
Tumor-draining lymph node-derived tumor-specific memory CD8 + T cells: a key player in PD-1/PD-L1 immunotherapy. Signal transduction and targeted therapy 8 (1) (2023)
Xinfeng Wang, Yuan Li, Runsen Jin, Sufei Zheng, Yuejun Luo, Peng Wu, Zhanyu Wang, Yuxin Yao, Nan Sun, Jie He
Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
Zheng Wu, Fengwei Tan, Yaozeng Xie, Wei Tang, Fei Wang, Yongjie Xu, Wei Cao, Chao Qin, Xuesi Dong, Yadi Zheng, Zilin Luo, Chunping Wang, Liang Zhao, Changfa Xia, Jiang Li, Renda Li, Feiyue Feng, Jibin Li, Jiansong Ren, Ju-Fang Shi, Hong Cui, Sipeng Shen, Ning Wu, Wan-Qing Chen, Ni Li, Jie He
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study. Cancer medicine (2023)
Enzhi Yin, Nan Sun, Jie He
Tumor-draining lymph node-derived tumor-specific memory CD8 + T cells: a key player in PD-1/PD-L1 immunotherapy. Signal transduction and targeted therapy 8 (1) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
Dongyu Li, Jingnan Wang, Chengming Liu, Yuejun Luo, Haiyan Xu, Yan Wang, Nan Sun, Jie He
Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs. Biomedicines 11 (4) (2023)
Yun Che, Zhiwen Luo, Yanan Cao, Nan Sun, Qi Xue, Jie He
PD-L1 predicts chemotherapy resistance in large-cell neuroendocrine carcinoma. The British journal of surgery (2022)
Yuejun Luo, Zhihui Zhang, Bo Zheng, Peng Wu, Guochao Zhang, Lide Wang, Qingpeng Zeng, Zhaoyang Yang, Liyan Xue, Hua Zeng, Fengwei Tan, Qi Xue, Shugeng Gao, Nan Sun, Jie He
Comprehensive analyses of N 6 -methyladenosine-related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer. Cancer science (2022)
Peng Song, Wenbin Li, Xiaoxuan Wu, Zhirong Qian, Jianming Ying, Shugeng Gao, Jie He
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. Cancer immunology, immunotherapy : CII 71 (10) (2022)
Zheng Wu, Fei Wang, Wei Cao, Chao Qin, Xuesi Dong, Zhuoyu Yang, Yadi Zheng, Zilin Luo, Liang Zhao, Yiwen Yu, Yongjie Xu, Jiang Li, Wei Tang, Sipeng Shen, Ning Wu, Feng-Wei Tan, Ni Li, Jie He
Lung cancer risk prediction models based on pulmonary nodules: A systematic review. Thoracic cancer 13 (5) (2022)
Nan Sun, Yuejun Luo, Bo Zheng, Zhihui Zhang, Chaoqi Zhang, Zhen Zhang, Guochao Zhang, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma. Journal of translational medicine 20 (1) (2022)
Chengming Liu, Sufei Zheng, Zhiliang Lu, Zhanyu Wang, Sihui Wang, Xiaoli Feng, Yan Wang, Nan Sun, Jie He
S100A7 attenuates immunotherapy by enhancing immunosuppressive tumor microenvironment in lung squamous cell carcinoma. Signal transduction and targeted therapy 7 (1) (2022)
Yuejun Luo, Nan Sun, Jie He
Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC. Signal transduction and targeted therapy 7 (1) (2022)
Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xinfeng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer. Cancer communications (London, England) 42 (9) (2022)
Zhenlin Yang, He Tian, Lin Li, Chao Li, Jiachen Xu, Fenglong Bie, Ying Chen, Yanhua Tian, Guangyu Bai, Yue Peng, Junhui Yang, Tao Fan, Chu Xiao, Wenchao Liu, Lei Liu, Renda Li, Sijin Sun, Bo Zheng, Fengwei Tan, Jianming Ying, Chunxiang Li, Shugeng Gao, Jie He
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies. International journal of cancer 151 (5) (2022)
Guochao Zhang, Chaoqi Zhang, Lide Wang, Liyan Xue, Jia Jia, Zhichao Zuo, Nan Sun, Shugeng Gao, Qi Xue, Jie He
The prognostic value of tumor deposits and the impact on the TNM classification system in esophageal cancer patients. Journal of surgical oncology 123 (4) (2021)
Lingling Fang, Yun Che, Chaoqi Zhang, Jianbing Huang, Yuanyuan Lei, Zhiliang Lu, Nan Sun, Jie He
LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3. Molecular oncology 15 (11) (2021)
Chaoqi Zhang, Zhihui Zhang, Zhen Zhang, Yuejun Luo, Peng Wu, Guochao Zhang, Liyan Xue, Qingpeng Zeng, Lide Wang, Zhaoyang Yang, Hua Zeng, Bo Zheng, Fengwei Tan, Qi Xue, Shugeng Gao, Nan Sun, Jie He
The landscape of m6A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance. Molecular cancer 20 (1) (2021)
Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun, Jie He
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma. Cancer biology & medicine (2021)
Zhihui Zhang, Nan Sun, Jie He
Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs. Signal transduction and targeted therapy 6 (1) (2021)
Yan Song, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Jie He, Jing Huang
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma. Cancer biology & medicine (2021)
Lingling Fang, Yun Che, Chaoqi Zhang, Jianbing Huang, Yuanyuan Lei, Zhiliang Lu, Nan Sun, Jie He
PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR/Akt/NF-κB/IL8 pathway. Cell death discovery 7 (1) (2021)
Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun, Jie He
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer. Cancer biology & medicine 17 (3) (2021)
Xiao Chang, Junqiang Chen, Wencheng Zhang, Jinsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jima Lv, Jun Liang, Zhouguang Hui, Lvhua Wang, Yu Lin, Xiaohui Chen, Qi Xue, Yousheng Mao, Yushun Gao, Dali Wang, Feiyue Feng, Shugeng Gao, Jie He, Zefen Xiao
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy. Therapeutic advances in medical oncology 13 (2021)
Zhuoyu Yang, Yadi Zheng, Zheng Wu, Yan Wen, Gang Wang, Shuohua Chen, Fengwei Tan, Jiang Li, Shouling Wu, Min Dai, Ni Li, Jie He
Association between pre-diagnostic serum albumin and cancer risk: Results from a prospective population-based study. Cancer medicine 10 (12) (2021)
Feng Wang, Chaoqi Zhang, Hong Cheng, Chengming Liu, Zhiliang Lu, Sufei Zheng, Sihui Wang, Nan Sun, Jie He
TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2. Cell death & disease 12 (10) (2021)
Chengming Liu, Sufei Zheng, Sihui Wang, Xinfeng Wang, Xiaoli Feng, Nan Sun, Jie He
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma. Therapeutic advances in medical oncology 13 (2021)
Zhihui Zhang, Chaoqi Zhang, Zhaoyang Yang, Guochao Zhang, Peng Wu, Yuejun Luo, Qingpeng Zeng, Lide Wang, Qi Xue, Yi Zhang, Nan Sun, Jie He
m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer. Journal of hematology & oncology 14 (1) (2021)
Guochao Zhang, Chaoqi Zhang, Nan Sun, Liyan Xue, Zhaoyang Yang, Lingling Fang, Zhihui Zhang, Yuejun Luo, Shugeng Gao, Qi Xue, Juwei Mu, Yushun Gao, Fengwei Tan, Jie He
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China. Journal of cancer research and clinical oncology (2021)
Zhihui Zhang, Yuejun Luo, Chaoqi Zhang, Peng Wu, Guochao Zhang, Qingpeg Zeng, Lide Wang, Liyan Xue, Zhaoyang Yang, Hua Zeng, Bo Zheng, Fengwei Tan, Qi Xue, Shugeng Gao, Nan Sun, Jie He
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer. Cancer cell international 21 (1) (2021)
Zhenlin Yang, Yue Peng, Wei Guo, Jiachen Xu, Lin Li, He Tian, Renda Li, Lei Liu, Fengwei Tan, Shugeng Gao, Jie He
PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer. Thoracic cancer 12 (11) (2021)
Bin Qiu, Wei Guo, Fan Zhang, Fang Lv, Ying Ji, Yue Peng, Xiaoxi Chen, Hua Bao, Yang Xu, Yang W Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC. Nature communications 12 (1) (2021)
Yuanyuan Lei, Nan Sun, Guochao Zhang, Chengming Liu, Zhiliang Lu, Jianbing Huang, Chaoqi Zhang, Ruochuan Zang, Yun Che, Shuangshuang Mao, Lingling Fang, Xinfeng Wang, Sufei Zheng, Jie He
Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer. Clinical and translational medicine 10 (3) (2020)
Sijin Sun, Wei Guo, Zhen Wang, Xin Wang, Guochao Zhang, Hao Zhang, Renda Li, Yibo Gao, Bin Qiu, Fengwei Tan, Yushun Gao, Qi Xue, Shugeng Gao, Jie He
Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer medicine 9 (16) (2020)
Yuanyuan Lei, Zhiliang Lu, Jianbing Huang, Ruochuan Zang, Yun Che, Shuangshuang Mao, Lingling Fang, Chengming Liu, Xinfeng Wang, Sufei Zheng, Nan Sun, Jie He
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer. Cell death & disease 11 (10) (2020)
Jianbing Huang, Jiagen Li, Sufei Zheng, Zhiliang Lu, Yun Che, Shuangshuang Mao, Yuanyuan Lei, Ruochuan Zang, Chengming Liu, Xinfeng Wang, Lingling Fang, Nan Sun, Jie He
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state. Cancer science 111 (6) (2020)
Yuanyuan Lei, Ruochuan Zang, Zhiliang Lu, Guochao Zhang, Jianbing Huang, Chengming Liu, Zhanyu Wang, Shuangshuang Mao, Yun Che, Xinfeng Wang, Sufei Zheng, Lingling Fang, Nan Sun, Jie He
ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells. Cell death & disease 11 (10) (2020)
Xiaoshuang Feng, Gang Wang, Zhangyan Lyu, Shuohua Chen, Luopei Wei, Xin Li, Yan Wen, Yuheng Chen, Shuanghua Xie, Hong Cui, Hongda Chen, Jiang Li, Chunqing Lin, Jiansong Ren, Ju-Fang Shi, Shouling Wu, Min Dai, Ni Li, Jie He
The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes. International journal of cancer 147 (4) (2020)
Nan Sun, Shouguo Sun, Yibo Gao, Yuan Li, Zhiliang Lu, Zuyang Yuan, Yun Che, Jianbing Huang, Shuangshuang Mao, Yuanyuan Lei, Ruochuan Zang, Ning Li, Wei Cui, Jun Qi, Feng Chen, Jia Gao, Jinling Wang, Rong Min, Yan Chen, Guangli Shi, Fengwei Tan, Jie He
Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial. Cancer science 111 (5) (2020)
Wei Guo, Sijin Sun, Lei Guo, Peng Song, Xuemin Xue, Hao Zhang, Guochao Zhang, Zhen Wang, Bin Qiu, Fengwei Tan, Qi Xue, Yibo Gao, Shugeng Gao, Jie He
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics. Journal of cancer research and clinical oncology 146 (4) (2020)
Zhenlin Yang, Jiachen Xu, Lin Li, Renda Li, Yalong Wang, Yanhua Tian, Wei Guo, Zhijie Wang, Fengwei Tan, Jianming Ying, Yucheng Jiao, Shugeng Gao, Jie Wang, Yibo Gao, Jie He
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma. Nature communications 11 (1) (2020)
Chaoqi Zhang, Guochao Zhang, Nan Sun, Zhen Zhang, Liyan Xue, Zhihui Zhang, Haijun Yang, Yuejun Luo, Xiaoli Zheng, Yonglei Zhang, Yufen Yuan, Ruixue Lei, Zhaoyang Yang, Bo Zheng, Le Wang, Yun Che, Feng Wang, Sihui Wang, Shugeng Gao, Qi Xue, Yi Zhang, Jie He
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma. Signal transduction and targeted therapy 5 (1) (2020)
Shuangshuang Mao, Yuan Li, Zhiliang Lu, Yun Che, Jianbing Huang, Yuanyuan Lei, Yalong Wang, Chengming Liu, Xinfeng Wang, Sufei Zheng, Nan Sun, Jie He
PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing. Cancer medicine 8 (5) (2019)
Zhenlin Yang, Jiachen Xu, Renda Li, Yibo Gao, Jie He
PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy. Journal of cancer research and clinical oncology 145 (12) (2019)
Wei Guo, Songhua Cai, Fan Zhang, Fei Shao, Guochao Zhang, Yang Zhou, Liang Zhao, Fengwei Tan, Shugeng Gao, Jie He
Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
Ruochuan Zang, Xinfeng Wang, Runsen Jin, Yuanyuan Lei, Jianbing Huang, Chengming Liu, Sufei Zheng, Fang Zhou, Qian Wu, Nan Sun, Shugeng Gao, Jie He
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. Journal of translational medicine 17 (1) (2019)
Zhangyan Lyu, Ni Li, Gang Wang, Xiaoshuang Feng, Shuohua Chen, Kai Su, Fang Li, Luopei Wei, Xin Li, Shuanghua Xie, Lan-Wei Guo, Yuheng Chen, Fengwei Tan, Jian Yin, Hong Cui, Hong-Da Chen, Jiang Li, Jiansong Ren, Ju-Fang Shi, Shouling Wu, Min Dai, Jie He
Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study. International journal of cancer 144 (12) (2019)
Fei Shao, Xueying Yang, Wei Wang, Juhong Wang, Wei Guo, Xiaoli Feng, Susheng Shi, Qi Xue, Shugeng Gao, Yibo Gao, Zhimin Lu, Jie He
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis. Cancer communications (London, England) 39 (1) (2019)
Hao Zhang, Fei Shao, Wei Guo, Yibo Gao, Jie He
Knockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancer. Thoracic cancer 10 (5) (2019)
Fengwei Tan, Yalong Wang, Shugeng Gao, Qi Xue, Juwei Mu, Yousheng Mao, Yushun Gao, Jun Zhao, Dali Wang, Lina Zhou, Jie He
Solitary fibrous tumors of the pleura: A single center experience at National Cancer Center, China. Thoracic cancer 9 (12) (2018)
Ning Li, Fengwei Tan, Jiagen Li, Kang Shao, Jun Zhao, Juwei Mu, Shugeng Gao, Jie He
Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patients. Thoracic cancer 9 (4) (2018)
Zhiliang Lu, Zhaoli Chen, Yuan Li, Jingnan Wang, Zhirong Zhang, Yun Che, Jianbing Huang, Shouguo Sun, Shuangshuang Mao, Yuanyuan Lei, Yibo Gao, Jie He
TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling. Journal of molecular medicine (Berlin, Germany) 96 (3-4) (2018)
Jianbing Huang, Yuan Li, Zhiliang Lu, Yun Che, Shouguo Sun, Shuangshuang Mao, Yuanyuan Lei, Ruochuan Zang, Ning Li, Nan Sun, Jie He
Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma. Cancer medicine (2018)
Jingnan Wang, Zhirong Zhang, Yun Che, Zuyang Yuan, Zhiliang Lu, Yuan Li, Jun Wan, Handong Sun, Zhaoli Chen, Pema-Tenzin Puno, Jie He
Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma. Cancer chemotherapy and pharmacology 81 (3) (2018)
Mei Luo, Yuan Li, Xuejiao Shi, Wenhui Yang, Fang Zhou, Nan Sun, Jie He
Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Cancer science 109 (6) (2018)